Literature DB >> 32920139

Ketone metabolism in the failing heart.

Gary D Lopaschuk1, Qutuba G Karwi2, Kim L Ho3, Simran Pherwani3, Ezra B Ketema3.   

Abstract

The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a "thrifty fuel", increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fatty acid oxidation; Glucose oxidation; Heart failure; Ketone body; NLRP3 inflammasome; Sodium glucose co-transporter 2 inhibitors

Mesh:

Substances:

Year:  2020        PMID: 32920139     DOI: 10.1016/j.bbalip.2020.158813

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  20 in total

Review 1.  Heart failure in diabetes.

Authors:  Stanislovas S Jankauskas; Urna Kansakar; Fahimeh Varzideh; Scott Wilson; Pasquale Mone; Angela Lombardi; Jessica Gambardella; Gaetano Santulli
Journal:  Metabolism       Date:  2021-10-08       Impact factor: 8.694

Review 2.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 3.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 4.  Mitochondrial Homeostasis Mediates Lipotoxicity in the Failing Myocardium.

Authors:  Tom Kretzschmar; Jasmine M F Wu; P Christian Schulze
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

5.  Energy metabolism homeostasis in cardiovascular diseases.

Authors:  Lu-Yun Wang; Chen Chen
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

6.  Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure.

Authors:  Kaijing Yang; Yitao Xue; Miao Yu; Huachen Jiao; Yan Li; Xijin Wei; Wenwen Liu; Yang Sun; Nannan Chen; Linlin Song; Ting Yu; Kaiming Chen; Dadong Guo
Journal:  Biomed Res Int       Date:  2022-01-19       Impact factor: 3.411

7.  The Effects of Fasting or Ketogenic Diet on Endurance Exercise Performance and Metabolism in Female Mice.

Authors:  Lola E Holcomb; Caitlin C O'Neill; Elizabeth A DeWitt; Stephen C Kolwicz
Journal:  Metabolites       Date:  2021-06-18

Review 8.  Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease.

Authors:  Kevin M Casin; John W Calvert
Journal:  Antioxidants (Basel)       Date:  2021-03-04

9.  NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.

Authors:  Qing Kong; Jinping Gu; Ruohan Lu; Caihua Huang; Xiaomin Hu; Weifeng Wu; Donghai Lin
Journal:  Biomolecules       Date:  2022-01-11

Review 10.  Ketone Body Metabolism in the Ischemic Heart.

Authors:  Stephen C Kolwicz
Journal:  Front Cardiovasc Med       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.